FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs
The Food and Drug Administration (FDA) announced a shame list of companies that try to block generic drugs in order to ramp up profits.
Pharmaceutical companies argue that they spend billions of dollars to research and develop new drugs, which they don’t want competitors profiting from by making cheaper generic copies of these medicines. These companies often fight for patent extensions, seek new uses for old products and sometimes prevent generic drug companies from obtaining samples.
Here are the 40 companies that made the FDA’s list:
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Ranbaxy Laboratories
Sun Pharmaceutical Industries Limited
Galena Biopharma, Inc.
Roche Palo Alto, LLC
Bayer AG
Novartis AG (ADR) (NYSE:NVS)
Mylan NV (NASDAQ:MYL)
Acorda Therapeutics Inc (NASDAQ:ACOR)
AstraZeneca plc (ADR) (NYSE:AZN)
Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE:TEVA)
HLS Therapeutics, Inc
Orphan Europe SARL
King Pharmaceuticals Inc.
Cubist Pharmaceuticals
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Cephalon (MM)
ApoPharma Inc
Shire Plc
NPS Pharmaceuticals Inc
Boehringer Ingelheim GmbH
Questcor Pharmaceuticals Inc
Pharmacia & Upjohn Inc
Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)
Corcept Therapeutics Incorporated (NASDAQ:CORT)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Gilead Sciences, Inc. (NASDAQ:GILD)
Roxane Laboratories, Inc.
Danco Laboratories LLC
Meda Pharmaceuticals Inc
Actelion Ltd.
Swedish Orphan Biovitrum AB
Celgene Corporation (NASDAQ:CELG)
GlaxoSmithKline plc (ADR) (NYSE:GSK)
VIVUS, Inc. (NASDAQ:VVUS)
Hyperion Therapeutics Inc
H. Lundbeck A/S
Insys Therapeutics Inc (NASDAQ:INSY)
Biogen Inc (NASDAQ:BIIB)
Pfizer Inc. (NYSE:PFE)
Valeant Pharmaceuticals Intl Inc (NYSE:VRX)
More From InvestorPlace
The post FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs appeared first on InvestorPlace.
